University of Minnesota. Driven to Discover.
In other developments, the HHS announced more funding for a rapid Ebola test.
The contract is for bolstering monoclonal antibody treatment for Ebola.
As cases drop slightly, vaccine trials suffer from lack of patients. Also, the NIH announces a trial involving survivors.
Funding will be used to continue trials of BCX4430 and prepare for its large-scale manufacture.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.